Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Serum [25(OH)D] was positively associated with sleep duration, sleep efficiency, and SRI, and negatively associated with sleep duration regularity, sleep onset timing regularity, and sleep midpoint timing regularity in model 1 (all p < .03) and model 4 (all p < .02).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were also excluded, if they had a history of any major chronic diseases or conditions, including cardiovascular, renal, metabolic, autoimmune, or cancerous conditions, as well as a recent history of coronavirus disease 2019 infection (<60 days) or vaccination (<14 days).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Serum 25-hydroxyvitamin D concentration is associated with device-estimated sleep metrics in healthy young and early middle-aged adults

Study design awaiting verification · Sleep Advances: A Journal of the Sleep Research Society · 2025

Original publication title

Serum 25-hydroxyvitamin D concentration is associated with device-estimated sleep metrics in healthy young and early middle-aged adults

Michele N D’Agata; Elissa K Hoopes; Thomas Keiser; Freda Patterson; Benjamin C Brewer; Melissa A Witman

© The Author(s) 2025. Published by Oxford University Press on behalf of Sleep Research Society.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Serum [25(OH)D] is independently associated with several sleep metrics in healthy adults. However, nighttime melatonin concentration did not mediate these associations, thus other mechanistic pathways must be considered.

An extract from the source publication. Read it in context.

At a glance

Abstract: Study Objectives

We tested associations between serum 25-hydroxyvitamin D concentration ([25(OH)D]) and device-estimated sleep metrics, including sleep duration, sleep efficiency, sleep duration regularity, sleep timing regularity, and sleep regularity index (SRI), in young and early middle-aged adults (18 to 45 years). We also assessed the mediating effect of nighttime melatonin (urinary 6-sulfatoxymelatonin (aMT6s) excretion) on these associations.

Source: Study Objectives

Abstract: What methods does the paper describe?

Participants (n = 79) completed 14 days of wrist actigraphy. Fasted blood sampling was performed to quantify serum [25(OH)D]. First morning void was used to quantify overnight urinary aMT6s excretion, normalized to creatinine clearance. Associations between [25(OH)D] and sleep metrics were evaluated using linear regression (model 1). Separate models adjusted for age, sex, race, and body fat % (model 2), season of testing, caffeine consumption, and education level (model 3), and device-estimated moderate-to-vigorous physical activity (model 4; n = 68).

Source: Methods

Abstract: Results

Serum [25(OH)D] was positively associated with sleep duration, sleep efficiency, and SRI, and negatively associated with sleep duration regularity, sleep onset timing regularity, and sleep midpoint timing regularity in model 1 (all p < .03) and model 4 (all p < .02). In model 2, serum [25(OH)D] remained significantly associated with sleep duration only (p = .036). In model 3, serum [25(OH)D] remained significantly associated with all sleep metrics (p < .02) except sleep duration regularity and SRI.

Serum [25(OH)D] was not associated with aMT6s:creatinine, indicating no grounds for performing mediation analyses.

Source: Results

Abstract: Conclusions

Serum [25(OH)D] is independently associated with several sleep metrics in healthy adults. However, nighttime melatonin concentration did not mediate these associations, thus other mechanistic pathways must be considered.

Source: Conclusions
Authors’ abstract

Abstract

Study Objectives

We tested associations between serum 25-hydroxyvitamin D concentration ([25(OH)D]) and device-estimated sleep metrics, including sleep duration, sleep efficiency, sleep duration regularity, sleep timing regularity, and sleep regularity index (SRI), in young and early middle-aged adults (18 to 45 years). We also assessed the mediating effect of nighttime melatonin (urinary 6-sulfatoxymelatonin (aMT6s) excretion) on these associations.

Methods

Participants (n = 79) completed 14 days of wrist actigraphy. Fasted blood sampling was performed to quantify serum [25(OH)D]. First morning void was used to quantify overnight urinary aMT6s excretion, normalized to creatinine clearance. Associations between [25(OH)D] and sleep metrics were evaluated using linear regression (model 1). Separate models adjusted for age, sex, race, and body fat % (model 2), season of testing, caffeine consumption, and education level (model 3), and device-estimated moderate-to-vigorous physical activity (model 4; n = 68).

Results

Serum [25(OH)D] was positively associated with sleep duration, sleep efficiency, and SRI, and negatively associated with sleep duration regularity, sleep onset timing regularity, and sleep midpoint timing regularity in model 1 (all p < .03) and model 4 (all p < .02). In model 2, serum [25(OH)D] remained significantly associated with sleep duration only (p = .036). In model 3, serum [25(OH)D] remained significantly associated with all sleep metrics (p < .02) except sleep duration regularity and SRI.

Serum [25(OH)D] was not associated with aMT6s:creatinine, indicating no grounds for performing mediation analyses.

Conclusions

Serum [25(OH)D] is independently associated with several sleep metrics in healthy adults. However, nighttime melatonin concentration did not mediate these associations, thus other mechanistic pathways must be considered.

Statement of Significance Here, we utilize 14 days of wrist actigraphy to evaluate cross-sectional associations between serum 25-hydroxyvitamin D ([25(OH)D]) concentration and device-estimated sleep metrics in a sample of healthy adults without evidence of clinical sleep disorders. Our results highlight significant associations between [25(OH)D] and several sleep metrics in this population, extending findings previously observed in only older adults and individuals with sleep disorders. We also newly assess the influence of urinary aMT6s excretion, an indicator of nighttime melatonin production, on the association between [25(OH)D] and sleep, given that melatonin has been proposed as a potential mechanism linking the two.

Findings show that nighttime melatonin does not mediate the associations between [25(OH)D] and device-estimated sleep metrics, suggesting other mechanistic pathways should be explored.

Publication and source details

Original title: Serum 25-hydroxyvitamin D concentration is associated with device-estimated sleep metrics in healthy young and early middle-aged adults

Michele N D’Agata; Elissa K Hoopes; Thomas Keiser; Freda Patterson; Benjamin C Brewer; Melissa A Witman

Sleep Advances: A Journal of the Sleep Research Society · 2025

Corresponding author. Melissa A. Witman, Department of Kinesiology and Applied Physiology, College of Health Sciences, University of Delaware, STAR Health Sciences Complex, 540 S. College Avenue, Newark, DE 19716, United States. Email: mwitman@udel.edu.© The Author(s) 2025. Published by Oxford University Press on behalf of Sleep Research Society.2025https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. National Institute of General Medical Sciences of the National Institutes of Health 2P20GM113125 American Heart Association10.13039/100000968 Award #831488

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:54:52.402328+00:00

DOI: 10.1093/sleepadvances/zpaf077 · PMC12670636